Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
East Coast Life Sciences Roundup: Verdine, Vedanta, Alnylam, & More 07/05/13 Boston
Xconomy Boston’s Top 20 Stories of Q2 2013: Editor’s Picks 07/01/13 Boston
The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013 06/03/13 National
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Brook Byers of Kleiner Perkins on Sticking With Healthcare 01/16/13 San Francisco
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Gladstone, Sage Bionetworks Top ‘Best Places to Work’ List 08/01/12 National
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Epizyme Gets $90M in Epigenetics Partnership with Celgene 04/26/12 Boston
Join Us for a Tweetchat Monday on Biotech Startups 12/02/11 National
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme 10/26/11 National
VC Investment in MA Companies Falls Back to Earth (from $1B to $505M): Top 10 Q3 Deals 10/24/11 Boston
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News 04/01/11 Boston
Epizyme, Riding High on Two Big Pharma Deals, Zeroes in on Personalized Cancer Therapy 03/29/11 Boston
World Energy Backs Retroficiency, American Superconductor Gets Finnish Firm, BuyWithMe Buys LocalTwist, & More Boston-Area Deals News 03/16/11 Boston
Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News 03/11/11 Boston
Epizyme Takes $6M Upfront in Cancer Drug Deal with Eisai 03/10/11 Boston
$12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals 01/12/11 Boston
Epizyme Nabs $650M Deal With Glaxo To Hunt for Epigenetic Drugs 01/10/11 Boston
MIT Cancer Research Star Tyler Jacks Takes Closing Keynote Role at Xconomy Forum 09/28/10 Boston
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer 06/08/10 Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
Page 2 of 3 « previous page · next page »